Skip to Main Content

Paper Details

Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years.
Stroke
382
2011
Author NameAffiliation
Opeolu AdeoyeUC Neuroscience Institute, University of Cincinnati Medical Center
  • 1 - 1

Datasets

Release 1.2